Basilea Pharmaceutica AG (BPMUF) Financials

BPMUF Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 366.4 million 166.8 million
Dec. 31, 2025 355.6 million 194.3 million
June 30, 2025 313.9 million 183.8 million
Dec. 31, 2024 285.0 million 195.5 million

BPMUF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 22.8 million ?
Dec. 31, 2025 46.3 million ?
June 30, 2025 28.7 million 3.6 million
Dec. 31, 2024 60.9 million 2.8 million

BPMUF Net Income

No data available :(

BPMUF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 216.4 million 86.9 million 13.2 million
Dec. 31, 2025 204.7 million 95.1 million 17.4 million
June 30, 2025 161.9 million 103.4 million 18.7 million
Dec. 31, 2024 133.5 million 106.1 million 17.4 million

BPMUF Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 17.1 million
Dec. 31, 2025 15.4 million
June 30, 2025 17.5 million
Dec. 31, 2024 15.3 million

BPMUF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 502849 66.4 million 22.1 million -
Dec. 31, 2025 2.9 million 85.3 million 22.9 million -
June 30, 2025 404863 48.3 million 21.5 million -
Dec. 31, 2024 1.5 million 48.2 million 18.2 million -

BPMUF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 146.3 million 19.0 million
Dec. 31, 2025 162.0 million 19.0 million
June 30, 2025 131.1 million 78.9 million
Dec. 31, 2024 146.2 million -14.4 million

BPMUF

Price: $76.25

52 week price:
59.29
77.40

Earnings Per Share: 3.93 USD

P/E Ratio: 19.69

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 943.7 million

Links: